600664:SHA
Harbin Pharmaceutical Group Co Ltd
CNÂ¥6.99
arrow_downward
-1.96%(-0.14) 1D
Sep 11, 3:00:03 PM GMT+8 · CNY
search
All symbols
1D
5D
1M
6M
YTD
1Y
5Y
MAX
| Symbol | Price | Change | % Change |
|---|
insights_autoGenerating top insights for 600664...
Open
CNÂ¥7.06
High
CNÂ¥7.18
Low
CNÂ¥6.92
Mkt. cap
17.96B
Avg. vol.
399.26M
Volume
273.68M
P/E ratio
34.37
52-wk high
CNÂ¥9.51
52-wk low
CNÂ¥2.84
EPS
CNÂ¥0.20
Shares outstanding
2.54B
No. of employees
10K
Open
CNÂ¥7.06
High
CNÂ¥7.18
Low
CNÂ¥6.92
Mkt. cap
17.96B
Avg. vol.
399.26M
Volume
273.68M
P/E ratio
34.37
52-wk high
CNÂ¥9.51
52-wk low
CNÂ¥2.84
EPS
CNÂ¥0.20
Shares outstanding
2.54B
No. of employees
10K
Profile
Harbin Pharmaceutical Group Co., Ltd. is a Chinese partially state-owned company engaged in the research & development, manufacture, and sale of pharmaceutical products. HPGC medication offerings include traditional Chinese medicine and biopharmaceuticals; its main offerings include antibiotics, including amoxicillin and penicillin, and dietary supplements, including zinc gluconate and calcium gluconate.
The company owns both Renmintongtai, a drugstore chain and medical wholesaler for the domestic market, and GNC, a U.S.-based international retailer of supplements and wellness products. Wikipedia
About Harbin Pharmaceutical Group Co Ltd